Insulin resistance (IR) occurs when the body's cells do not respond effectively to insulin, a hormone crucial for regulating blood sugar [2, 6]. This diminished response can lead to higher blood sugar levels and is a central factor in the development of various metabolic disorders [5, 6]. When several of these metabolic issues cluster together—including abdominal obesity, high blood pressure, elevated blood sugar, high triglycerides, and low 'good' HDL cholesterol—it is known as metabolic syndrome [3, 6]. These conditions are often interlinked, forming what is increasingly recognized as Cardiovascular-Kidney-Metabolic (CKM) syndrome, highlighting the deep connection between metabolic health, heart disease, and kidney function [6]. Obesity is a significant contributor to both insulin resistance and cardiometabolic diseases [2].
The Role of Adipose Tissue and Iron Metabolism
Insulin resistance can manifest differently across various tissues in the body [2]. Research indicates that insulin resistance in adipose (fat) tissue, rather than muscle tissue, is more strongly associated with an unfavorable cardiometabolic profile [2]. This includes increased abdominal fat accumulation, higher fasting insulin levels, and elevated triglycerides, all of which contribute to a greater risk of metabolic complications [2].
Beyond adipose tissue, iron metabolism also plays a vital role in how cells respond to insulin [1]. A connection between iron metabolism, iron deficiency, and insulin resistance is well-documented, particularly in children and adolescents with obesity [1]. While dietary factors are not typically the primary cause of iron deficiency in children, weight reduction has been shown to help restore iron balance in individuals with obesity [1]. Therefore, optimizing obesity management, especially in younger populations, can help prevent both iron deficiency and related metabolic complications [1].
Lifestyle Interventions: The Foundation of Health
Fundamental to managing insulin resistance and metabolic syndrome are healthy lifestyle behaviors [6]. These include adopting a balanced diet, engaging in regular physical activity, ensuring adequate sleep, and effectively managing stress [6]. For individuals with type 2 diabetes, behavioral weight management programs, particularly those enhanced with continuous glucose monitoring (CGM), have demonstrated significant benefits [7]. Such programs have been shown to reduce HbA1c (a measure of average blood sugar) and body weight more effectively than usual care, leading to better glycemic control and weight loss [7]. In children and adolescents, focusing on improved dietary habits and increasing awareness of iron's importance are key components of obesity management strategies aimed at preventing metabolic issues [1].
Medication Options for Metabolic Health
For many individuals, lifestyle changes alone may not be sufficient, and pharmacologic interventions become important for managing metabolic risks [3, 6]. In patients with coronary artery disease, for example, integrating metabolic risk management with cardiovascular care is crucial for improving outcomes [3]. Medications such as SGLT2 inhibitors and GLP-1 receptor agonists are among the therapeutic strategies highlighted for their effectiveness in addressing metabolic risk factors [3, 6].
Additionally, incretin-based obesity management medications (OMMs) represent a significant advance, offering a treatment option between lifestyle changes and surgical interventions [8]. These medications can lead to substantial weight loss, often 15% to 20% of body weight [8]. While there is growing interest and demand for OMMs, cost and access remain significant barriers for many patients [8]. It is important for patients to have informed discussions with their healthcare providers to weigh the risks and benefits of various treatment options [8].
Considering Metabolic and Bariatric Surgery
For individuals with significant obesity and related metabolic diseases, metabolic and bariatric surgery (MBS) can be a highly effective intervention [4]. These gastrointestinal surgeries are designed to promote weight loss and resolve metabolic conditions [4]. MBS can lead to remission of type 2 diabetes, hypertension, and sleep apnea in many patients, and has been shown to prolong life expectancy by 5 to 9 years [4].
Professional guidelines recommend MBS for adults with a body mass index (BMI) of 35 kg/m² or higher, and for those with type 2 diabetes with a BMI of 30 kg/m² or higher [4]. For children aged 13 years and older, MBS is also recommended and has not been found to negatively affect height or development [4]. While MBS procedures carry a very low risk of surgical complications, they require careful preoperative counseling due to the significant long-term lifestyle changes involved [4].
Why Comprehensive Management Matters
Metabolic abnormalities, including insulin resistance, are major drivers in the progression of serious health conditions like coronary artery disease and the development of heart failure [3, 5]. The concept of CKM syndrome underscores the interconnectedness of cardiovascular, kidney, and metabolic diseases, with insulin resistance playing a central role in their pathophysiology [6]. A comprehensive approach that integrates lifestyle modifications, appropriate medications, and, when indicated, surgical interventions, is essential for optimizing health outcomes [3]. Discussing personalized treatment strategies with a healthcare provider is key to navigating these complex conditions effectively [4, 8].
Sources
- [1] The Interplay Between Iron Metabolism and Insulin Resistance: A Key Factor in Optimizing Obesity Management in Children and Adolescents. https://pubmed.ncbi.nlm.nih.gov/40218969/
- [2] Adipose tissue insulin resistance, not muscle insulin resistance, is associated with impaired metabolic health in humans. https://pubmed.ncbi.nlm.nih.gov/42543083/
- [3] Managing metabolic risks in coronary artery disease: A scoping review of recent clinical and therapeutic evidence. https://pubmed.ncbi.nlm.nih.gov/41867418/
- [4] Obesity Management: Surgical Interventions. https://pubmed.ncbi.nlm.nih.gov/42101583/
- [5] Association of obesity-metabolic indices with heart failure in patients with coronary artery disease: a multicenter retrospective observational study. https://pubmed.ncbi.nlm.nih.gov/42077447/
- [6] Cardiovascular-kidney-metabolic (CKM) syndrome. https://pubmed.ncbi.nlm.nih.gov/42312302/
- [7] Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/42047631/
- [8] Decoding Obesity Management Medications and the Journey to Informed Treatment Choices for Patients. https://pubmed.ncbi.nlm.nih.gov/39641717/